Cel­gene is squeez­ing the trig­ger on an ear­ly FDA fil­ing for key Agios can­cer drug

Six years af­ter Cel­gene helped get the R&D ball rolling at Agios with a world­wide pact that cov­ered the glob­al rights for its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.